Experience with the new hydrophobic acrylic trifocal IOL

Session Details

Session Title: Corneal and Intraocular Correction of Presbyopia

Session Date/Time: Monday 12/09/2016 | 08:00-09:30

Paper Time: 08:48

Venue: Hall C2

First Author: : K.Buusova Smeckova CZECH REPUBLIC

Co Author(s): :    Z. Smecka   B. Strnadova   A. Kovacikova              

Abstract Details

Purpose:

The aim of our paper is to evaluate our first experience with the Alcon AcrySof IQ PanOptix IOL as a new treatment option in both cataract surgery and RLE. As long as a toric version of the IOL is not available yet, both astigmatism tolerance and biopics results included, as well as the first experience with NdYAG capsulotomy and post-PRK patients.

Setting:

Eye Clinic Zlin, Zlin, Czech Republic

Methods:

150 eyes of 77 patients. 10 eyes with previous PRK. Up to -2,5D of corneal astigmatism (treated at least 2 months after the procedure by LASIK when needed). Autorefractometry and BCVA measurements performed, as well as the standard preoperative examinations. Uneventful cataract or RLE procedure followed by PanOptix IOL implantation - range of the IOL: +14,5 to +30D. Postoperatively 6 weeks follow up. UCDVA, UCIVA (both 66 and 80 cm) and UCNVA monocular testing performed. Autorefractometry measurements, overall patient satisfaction and any complaints from the patient have been recorded. Experience with NdYAG capsulotomy and biopics recorded as well.

Results:

Results from the check up at six weeks after the procedure: Autorefractometry values Dsf: 0,4 [-0,7;1,25], Dcyl: [-2,25;0]. Postoperative UCDVA in the group with corneal cylinder lower than 1: 0,7 and better. UCDVA of all patients 0,88 [0,3;1,1]. UCIVA: both at 66 and 80 cm 29% 1,0 and better, 98% 0,8 and better. NUCVA: 41% J.1 and better, 96% J.2 and better, 99,3% J.3 and better (high corneal astigmatism). In post- PRK group 0,9 UCDVA, 0,8 UCIVA and at least J.2 UCNVA have been gained. No major complaints about halo and glare have been reported at 6 weeks. NdYAG capsulotomy performed in 2 patients with posterior subcapsular cataract without complications. Biopics needed in 4 patients (above -1,5 Dcyl). Predictable outcomes.

Conclusions:

The new trifocal IOL PanOptix was long awaited. Patient satisfaction is, based on our previous experience, greater with PanOptix than with the ReSTOR. Halo and glare does not seem to be a big issue. Although quite frequent immediately after the procedure, no-one found it really disappointing at 6 weeks. Adaptation to the AcrySof IQ PanOptix is fast, patients usually see for the near and intermediate at a decent level already during the first days after the surgery, depending on the recovery. Intermediate distance vision is very good and continuously passes from 66 to 80 cm, often even more.

Financial Disclosure:

NONE